Atom | Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional)

Due Dates: June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision)

Funding Amounts: No budget limit; budgets must reflect actual project needs. Maximum project period: 5 years.

Summary: Supports research integrating imaging, biomarkers, and digital pathomics to improve early detection of aggressive cancer and identification of precancerous lesions with lethal potential.

Key Information: Clinical trial proposals are optional; all funded projects will participate in the Consortium for Imaging and Biomarkers (CIB) program.

Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional)

Sign in to see full grant listing